Analyst Downgrades – RMD – ResMed (NYSE:RMD) Stock Gets Downgraded By Citigroup from Buy to Neutral

ME Staff
-
0

Analyst Ratings For RMD – ResMed (NYSE:RMD)

Today, RMD – ResMed (NYSE:RMD) stock was downgraded by Citigroup from Buy to Neutral.

Some recent analyst ratings include

  • 4/4/2018-Citigroup was Downgraded by analysts at Citigroup from a “Buy ” rating to a ” Neutral” rating.
  • 3/7/2018-Needham & Company LLC Reiterated Rating of Hold.
  • 1/23/2018-Northland Securities Upgrade from a “Under Perform ” rating to a ” Market Perform” rating.
  • 1/23/2018-Macquarie was Downgraded by analysts at Macquarie from a “Neutral ” rating to a ” Sell” rating.

Dividend information for RMD – ResMed (NYSE:RMD)

RMD – ResMed (NYSE:RMD) pays an annual dividend of $1.40 with a yield of 1.48% and an average dividend growth of 8.70% based on a 3 Year Average..

Dividend History for RMD – ResMed (NYSE:RMD)

  • On 1/22/2018 RMD – ResMed announced a quarterly dividend of $0.35 1.42% with an ex dividend date of 2/7/2018 which will be payable on 3/15/2018.
  • On 10/26/2017 RMD – ResMed announced a quarterly dividend of $0.35 1.66% with an ex dividend date of 11/8/2017 which will be payable on 12/14/2017.
  • On 8/2/2017 RMD – ResMed announced a quarterly dividend of $0.35 1.93% with an ex dividend date of 8/15/2017 which will be payable on 9/21/2017.
  • On 4/27/2017 RMD – ResMed announced a quarterly dividend of $0.33 1.94% with an ex dividend date of 5/9/2017 which will be payable on 6/15/2017.
  • On 1/23/2017 RMD – ResMed announced a quarterly dividend of $0.33 1.89% with an ex dividend date of 2/7/2017 which will be payable on 3/16/2017.
  • On 10/25/2016 RMD – ResMed announced a quarterly dividend of $0.33 2.18% with an ex dividend date of 11/8/2016 which will be payable on 12/15/2016.
  • On 7/28/2016 RMD – ResMed announced a quarterly dividend of $0.33 1.92% with an ex dividend date of 8/16/2016 which will be payable on 9/22/2016.

Recent Insider Trading Activity For RMD – ResMed (NYSE:RMD)
RMD – ResMed (NYSE:RMD) has insider ownership of 1.77% and institutional ownership of 62.40%.

  • On 4/2/2018 James Hollingshead, Insider, sold 600 with an average share price of $98.19 per share and the total transaction amounting to $58,914.00.
  • On 3/15/2018 Brett Sandercock, CFO, sold 2,000 with an average share price of $98.53 per share and the total transaction amounting to $197,060.00.
  • On 3/5/2018 David Pendarvis, Insider, sold 2,810 with an average share price of $94.08 per share and the total transaction amounting to $264,364.80.
  • On 3/1/2018 James Hollingshead, Insider, sold 600 with an average share price of $94.01 per share and the total transaction amounting to $56,406.00.
  • On 2/15/2018 Brett Sandercock, CFO, sold 2,000 with an average share price of $93.42 per share and the total transaction amounting to $186,840.00.
  • On 2/5/2018 David Pendarvis, Insider, sold 2,810 with an average share price of $96.03 per share and the total transaction amounting to $269,844.30.
  • On 2/1/2018 Brett Sandercock, CFO, sold 1,250 with an average share price of $100.13 per share and the total transaction amounting to $125,162.50.

Recent Trading Activity for RMD – ResMed (NYSE:RMD)
Shares of RMD – ResMed closed the previous trading session at 94.26 down -2.59 2.67% with 94.3499984741211 shares trading hands.